Ninth Circuit Says Nexus’ State Law Claims Against Compounding Pharmacy Preempted
- September 16, 2022
Nexus Pharmaceuticals’ state law claims against a network of compounding pharmacies are impliedly preempted because they conflict with federal food and drug law, which vests exclusive enforcement authority in the Food and Drug Administration (FDA), the Ninth Circuit held September 13.
ARTICLE TAGS
You must be logged in to access this content.